Recent publications published by researchers at the MRC WIMM.
Chantelle McGregor CG. et al, (2022), Cell Mol Gastroenterol Hepatol
Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response.
Adams A. et al, (2022), Gut
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease.
Wellens J. et al, (2022), Gut, 71, 1919 - 1922
Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic.
McGregor CG. et al, (2021), Gut, 70, 2398 - 2400